Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

LinkageMapView - Rendering High Resolution Linkage and QTL Maps.

Ouellette LA, Reid RW, Blanchard SG Jr, Brouwer CR.

Bioinformatics. 2017 Sep 13. doi: 10.1093/bioinformatics/btx576. [Epub ahead of print]

2.

Pathview Web: user friendly pathway visualization and data integration.

Luo W, Pant G, Bhavnasi YK, Blanchard SG Jr, Brouwer C.

Nucleic Acids Res. 2017 Jul 3;45(W1):W501-W508. doi: 10.1093/nar/gkx372.

3.

A Consensus Map in Cultivated Hexaploid Oat Reveals Conserved Grass Synteny with Substantial Subgenome Rearrangement.

Chaffin AS, Huang YF, Smith S, Bekele WA, Babiker E, Gnanesh BN, Foresman BJ, Blanchard SG, Jay JJ, Reid RW, Wight CP, Chao S, Oliver R, Islamovic E, Kolb FL, McCartney C, Mitchell Fetch JW, Beattie AD, Bjørnstad Å, Bonman JM, Langdon T, Howarth CJ, Brouwer CR, Jellen EN, Klos KE, Poland JA, Hsieh TF, Brown R, Jackson E, Schlueter JA, Tinker NA.

Plant Genome. 2016 Jul;9(2). doi: 10.3835/plantgenome2015.10.0102.

4.

Recommendations for responsible prescribing of radiographs in children.

Blanchard SG, Ralstrom EF.

J Mich Dent Assoc. 2013 Jan;95(1):30-4. No abstract available.

PMID:
23409328
5.

Genoviz Software Development Kit: Java tool kit for building genomics visualization applications.

Helt GA, Nicol JW, Erwin E, Blossom E, Blanchard SG Jr, Chervitz SA, Harmon C, Loraine AE.

BMC Bioinformatics. 2009 Aug 25;10:266. doi: 10.1186/1471-2105-10-266.

6.

The Integrated Genome Browser: free software for distribution and exploration of genome-scale datasets.

Nicol JW, Helt GA, Blanchard SG Jr, Raja A, Loraine AE.

Bioinformatics. 2009 Oct 15;25(20):2730-1. doi: 10.1093/bioinformatics/btp472. Epub 2009 Aug 4.

7.

Inhibition of cross-bridge formation has no effect on contraction-associated phosphorylation of p38 MAPK in mouse skeletal muscle.

Dentel JN, Blanchard SG, Ankrapp DP, McCabe LR, Wiseman RW.

Am J Physiol Cell Physiol. 2005 Apr;288(4):C824-30. Epub 2004 Dec 1.

8.

Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.

Stanley TB, Leesnitzer LM, Montana VG, Galardi CM, Lambert MH, Holt JA, Xu HE, Moore LB, Blanchard SG, Stimmel JB.

Biochemistry. 2003 Aug 12;42(31):9278-87. Erratum in: Biochemistry. 2006 Oct 3;45(39):12194.

PMID:
12899614
9.

Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.

Leesnitzer LM, Parks DJ, Bledsoe RK, Cobb JE, Collins JL, Consler TG, Davis RG, Hull-Ryde EA, Lenhard JM, Patel L, Plunket KD, Shenk JL, Stimmel JB, Therapontos C, Willson TM, Blanchard SG.

Biochemistry. 2002 May 28;41(21):6640-50.

PMID:
12022867
10.

A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity.

Rocchi S, Picard F, Vamecq J, Gelman L, Potier N, Zeyer D, Dubuquoy L, Bac P, Champy MF, Plunket KD, Leesnitzer LM, Blanchard SG, Desreumaux P, Moras D, Renaud JP, Auwerx J.

Mol Cell. 2001 Oct;8(4):737-47.

11.

A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma.

Wang Y, Porter WW, Suh N, Honda T, Gribble GW, Leesnitzer LM, Plunket KD, Mangelsdorf DJ, Blanchard SG, Willson TM, Sporn MB.

Mol Endocrinol. 2000 Oct;14(10):1550-6.

PMID:
11043571
12.

HIV protease inhibitors block adipogenesis and increase lipolysis in vitro.

Lenhard JM, Furfine ES, Jain RG, Ittoop O, Orband-Miller LA, Blanchard SG, Paulik MA, Weiel JE.

Antiviral Res. 2000 Aug;47(2):121-9.

PMID:
10996400
13.

Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands.

Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, Collins JL, Kliewer SA.

J Biol Chem. 2000 May 19;275(20):15122-7.

14.

Synthesis and biological activity of a novel series of indole-derived PPARgamma agonists.

Henke BR, Adkison KK, Blanchard SG, Leesnitzer LM, Mook RA Jr, Plunket KD, Ray JA, Roberson C, Unwalla R, Willson TM.

Bioorg Med Chem Lett. 1999 Dec 6;9(23):3329-34.

PMID:
10612594
15.

Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha.

Moya-Camarena SY, Vanden Heuvel JP, Blanchard SG, Leesnitzer LA, Belury MA.

J Lipid Res. 1999 Aug;40(8):1426-33.

16.

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.

Brown KK, Henke BR, Blanchard SG, Cobb JE, Mook R, Kaldor I, Kliewer SA, Lehmann JM, Lenhard JM, Harrington WW, Novak PJ, Faison W, Binz JG, Hashim MA, Oliver WO, Brown HR, Parks DJ, Plunket KD, Tong WQ, Menius JA, Adkison K, Noble SA, Willson TM.

Diabetes. 1999 Jul;48(7):1415-24.

PMID:
10389847
17.

A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation.

Oberfield JL, Collins JL, Holmes CP, Goreham DM, Cooper JP, Cobb JE, Lenhard JM, Hull-Ryde EA, Mohr CP, Blanchard SG, Parks DJ, Moore LB, Lehmann JM, Plunket K, Miller AB, Milburn MV, Kliewer SA, Willson TM.

Proc Natl Acad Sci U S A. 1999 May 25;96(11):6102-6.

18.

Bile acids: natural ligands for an orphan nuclear receptor.

Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, Lehmann JM.

Science. 1999 May 21;284(5418):1365-8.

19.

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors.

Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, Sternbach DD, Lehmann JM, Wisely GB, Willson TM, Kliewer SA, Milburn MV.

Mol Cell. 1999 Mar;3(3):397-403.

20.

Differential activity of rosiglitazone enantiomers at PPAR gamma.

Parks DJ, Tomkinson NC, Villeneuve MS, Blanchard SG, Willson TM.

Bioorg Med Chem Lett. 1998 Dec 15;8(24):3657-8.

PMID:
9934490
21.

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent.

Cobb JE, Blanchard SG, Boswell EG, Brown KK, Charifson PS, Cooper JP, Collins JL, Dezube M, Henke BR, Hull-Ryde EA, Lake DH, Lenhard JM, Oliver W Jr, Oplinger J, Pentti M, Parks DJ, Plunket KD, Tong WQ.

J Med Chem. 1998 Dec 3;41(25):5055-69.

PMID:
9836622
22.

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.

Henke BR, Blanchard SG, Brackeen MF, Brown KK, Cobb JE, Collins JL, Harrington WW Jr, Hashim MA, Hull-Ryde EA, Kaldor I, Kliewer SA, Lake DH, Leesnitzer LM, Lehmann JM, Lenhard JM, Orband-Miller LA, Miller JF, Mook RA Jr, Noble SA, Oliver W Jr, Parks DJ, Plunket KD, Szewczyk JR, Willson TM.

J Med Chem. 1998 Dec 3;41(25):5020-36.

PMID:
9836620
23.

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety.

Collins JL, Blanchard SG, Boswell GE, Charifson PS, Cobb JE, Henke BR, Hull-Ryde EA, Kazmierski WM, Lake DH, Leesnitzer LM, Lehmann J, Lenhard JM, Orband-Miller LA, Gray-Nunez Y, Parks DJ, Plunkett KD, Tong WQ.

J Med Chem. 1998 Dec 3;41(25):5037-54.

PMID:
9836621
24.

Discovery of bioavailable inhibitors of secretory phospholipase A2.

Blanchard SG, Andrews RC, Brown PJ, Gan LS, Lee FW, Sinhababu AK, Wheeler TN.

Pharm Biotechnol. 1998;11:445-63. Review.

PMID:
9760691
25.

Effects of a potent melanocortin agonist on the diabetic/obese phenotype in yellow mice.

Zemel MB, Moore JW, Moustaid N, Kim JH, Nichols JS, Blanchard SG, Parks DJ, Harris C, Lee FW, Grizzle M, James M, Wilkison WO.

Int J Obes Relat Metab Disord. 1998 Jul;22(7):678-83.

PMID:
9705029
26.

Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain.

Nichols JS, Parks DJ, Consler TG, Blanchard SG.

Anal Biochem. 1998 Mar 15;257(2):112-9. Erratum in: Anal Biochem 1998 Oct 1;263(1):126.

PMID:
9514791
27.

Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library.

Brown PJ, Smith-Oliver TA, Charifson PS, Tomkinson NC, Fivush AM, Sternbach DD, Wade LE, Orband-Miller L, Parks DJ, Blanchard SG, Kliewer SA, Lehmann JM, Willson TM.

Chem Biol. 1997 Dec;4(12):909-18.

28.

Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of ligand binding to the melanocortin receptors.

Kiefer LL, Ittoop OR, Bunce K, Truesdale AT, Willard DH, Nichols JS, Blanchard SG, Mountjoy K, Chen WJ, Wilkison WO.

Biochemistry. 1997 Feb 25;36(8):2084-90.

PMID:
9047307
29.

125I aqueous waste volume reduction at a pharmaceutical research laboratory.

Edwards BE, Couch NW, Myers KD, Blanchard SG, Chandra G, Parr AF.

Health Phys. 1996 Sep;71(3):379-83.

PMID:
8698582
30.

Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line.

Blanchard SG, Harris CO, Ittoop OR, Nichols JS, Parks DJ, Truesdale AT, Wilkison WO.

Biochemistry. 1995 Aug 22;34(33):10406-11.

PMID:
7544613
31.

Substrate specificity in short-chain phospholipid analogs at the active site of human synovial phospholipase A2.

Wheeler TN, Blanchard SG, Andrews RC, Fang F, Gray-Nunez Y, Harris CO, Lambert MH, Mehrotra MM, Parks DJ, Ray JA, et al.

J Med Chem. 1994 Nov 25;37(24):4118-29.

PMID:
7990112
32.

A fluorescence-based assay for human type II phospholipase A2.

Blanchard SG, Harris CO, Parks DJ.

Anal Biochem. 1994 Nov 1;222(2):435-40.

PMID:
7864369
33.
34.

Amiloride intercalates into DNA and inhibits DNA topoisomerase II.

Besterman JM, Elwell LP, Blanchard SG, Cory M.

J Biol Chem. 1987 Sep 25;262(27):13352-8.

35.

Characterization of the binding of a morphine (mu) receptor-specific ligand: Tyr-Pro-NMePhe-D-Pro-NH2, [3H]-PL17.

Blanchard SG, Lee PH, Pugh WW, Hong JS, Chang KJ.

Mol Pharmacol. 1987 Apr;31(4):326-33.

PMID:
3033464
36.

Phorbol ester receptors and protein kinase C in primary neuronal cultures: development and stimulation of endogenous phosphorylation.

Burgess SK, Sahyoun N, Blanchard SG, LeVine H 3rd, Chang KJ, Cuatrecasas P.

J Cell Biol. 1986 Jan;102(1):312-9.

37.

Benzomorphan sites are ligand recognition sites of putative epsilon-receptors.

Chang KJ, Blanchard SG, Cuatrecasas P.

Mol Pharmacol. 1984 Nov;26(3):484-8.

PMID:
6149459
39.
40.

Visualization of enkephalin receptors by image-intensified fluorescence microscopy.

Blanchard SG, Chang KJ, Cuatrecasas P.

Methods Enzymol. 1983;103:219-27. No abstract available.

PMID:
6321887
41.
42.

Studies on the mechanism of enkephalin receptor down regulation.

Blanchard SG, Chang KJ, Cuatrecasas P.

Life Sci. 1982 Sep 20-27;31(12-13):1311-4.

PMID:
6292620
43.

Opioid peptides induce reduction of enkephalin receptors in cultured neuroblastoma cells.

Chang KJ, Eckel RW, Blanchard SG.

Nature. 1982 Apr 1;296(5856):446-8. No abstract available.

PMID:
6278327
44.
45.
46.

Purification of Torpedo californica post-synaptic membranes and fractionation of their constituent proteins.

Elliott J, Blanchard SG, Wu W, Miller J, Strader CD, Hartig P, Moore HP, Racs J, Raftery MA.

Biochem J. 1980 Mar 1;185(3):667-77.

47.

The use of photochemical probes for studies of structure and function of purified acetylcholine receptor preparations.

Raftery MA, Witzemann V, Blanchard SG.

Ann N Y Acad Sci. 1980;346:458-74. No abstract available.

PMID:
6930192
48.

Interaction of local anesthetics with Torpedo californica membrane-bound acetylcholine receptor.

Blanchard SG, Elliott J, Raftery MA.

Biochemistry. 1979 Dec 25;18(26):5880-5.

PMID:
518874
49.

Specific binding of perhydrohistrionicotoxin to Torpedo acetylcholine receptor.

Elliott J, Dunn SM, Blanchard SG, Raftery MA.

Proc Natl Acad Sci U S A. 1979 Jun;76(6):2576-9.

50.

Interaction of [125I]-alpha-bungarotoxin with acetylcholine receptor from Torpedo californica.

Blanchard SG, Quast U, Reed K, Lee T, Schimerlik MI, Vandlen R, Claudio T, Strader CD, Moore HP, Raftery MA.

Biochemistry. 1979 May 15;18(10):1875-83. No abstract available.

PMID:
435451

Supplemental Content

Loading ...
Support Center